医学
肺炎
支气管肺泡灌洗
CD8型
队列
免疫系统
肺癌
肺
细胞毒性T细胞
免疫疗法
生物标志物
免疫学
过敏性肺炎
放射治疗
免疫检查点
PD-L1
外周血单个核细胞
肿瘤科
癌症研究
仿形(计算机编程)
癌症
内科学
病理
毒性
队列研究
T细胞
放射性肺炎
无容量
呼吸道疾病
基因表达谱
作者
X Y Zhou,Ziming Jiang,Yanhong Ren,Yunzhi Zhou,Lei Deng,Zhenting Liu,Sijin Sun,Jieli Zhang,Liu W,Yi Yang,W. Ren,Yanfeng Wang,Hui Li,Yiqun Li,Ma Fx,Nan Bi,Luhua Wang,Gao Y,Jie He
出处
期刊:Med
[Elsevier BV]
日期:2026-06-09
卷期号:7 (7): 101180-101180
标识
DOI:10.1016/j.medj.2026.101180
摘要
Background Checkpoint inhibitor pneumonitis (CIP) is the leading cause of treatment-related deaths for immune checkpoint inhibitor (ICI) combination therapies. CIP is problematic to diagnose and differentiate, particularly from radiation pneumonitis (RP), due to the lack of mechanistic distinctions between them. Methods Using single-cell RNA sequencing (scRNA-seq) and single-cell T cell receptor sequencing (scTCR-seq), we characterize the cellular landscape of bronchoalveolar lavage fluid (BALF) and peripheral blood from a discovery cohort (seven CIP, six RP, and six treatment-naive controls) and a validation cohort (five patients receiving combined ICI and radiotherapy who were diagnosed with RP). Findings We report a striking accumulation of alveolar CD8 + exhausted T cells (Texs) in CIP. The alveolar CD8 + Texs of CIP primarily differentiate from tissue-resident ZNF683 hi CD8 + T cells, whereas those of RP predominantly originate from peripherally related GZMK hi CD8 + T cells. These findings were further validated in a prospectively enrolled validation cohort and ultimately guided successful clinical decisions regarding ICI rechallenge. Conclusions These results highlight distinct cellular and molecular features in CIP and RP, thereby providing insights into clinical decision-making regarding ICI rechallenge in lung cancer patients. Funding This study was supported by the National Natural Science Foundation of China.
科研通智能强力驱动
Strongly Powered by AbleSci AI